Examination of Unplanned 30-Day Readmissions to a Comprehensive Cancer Hospital-Reference-Cited by-同舟云学术

Examination of Unplanned 30-Day Readmissions to a Comprehensive Cancer Hospital

Published:2015-03 Issue:2 Volume:11 Page:e177-e181
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Saunders Neil David¹,Nichols Shawnn D.¹,Antiporda Michael Alfredo¹,Johnson Kristen¹,Walker Kerri¹,Nilsson Rhonda¹,Graham Lisa¹,Old Matt¹,Klisovic Rebecca B.¹,Penza Sam¹,Schmidt Carl R.¹

Affiliation:

1. The Ohio State University Wexner Medical Center, Columbus, OH

Abstract

Most unplanned readmissions to a tertiary cancer hospital were related to progression of disease, new diagnoses, and procedure complications.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2014.001546

Reference15 articles.

1. Hospital Readmissions in the Medicare Population

2. Variation in Surgical-Readmission Rates and Quality of Hospital Care

3. The Association Between the Quality of Inpatient Care and Early Readmission

4. Readmission After Pancreatic Resection is not an Appropriate Measure of Quality

5. Unexpected Readmissions After Major Cancer Surgery

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unplanned Hospital Admissions in Patients With Solid Tumors in Brazil: Causes and Progressive Disease's Impact on Outcomes;JCO Global Oncology;2024-07

2. Understanding Potentially Preventable 7-day Readmission Rates in Hospital Medicine Patients at a Comprehensive Cancer Center;American Journal of Medical Quality;2023-12-28

3. The impact of a multidisciplinary goals-of-care program on unplanned readmission rates at a comprehensive cancer center;Supportive Care in Cancer;2023-12-27

4. Best analgesia control in pancreatic adenocarcinoma study: justification and feasibility of a randomised trial of early EUS-CPN versus standard care—a prospective observational study (The BAC-PAC study);BJC Reports;2023-09-18

5. Association of polypharmacy with all‐cause mortality and adverse events among elderly colorectal cancer survivors;Cancer;2023-04-28